+++
title = "U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication"
description = "The U.S. Supreme Court on Monday turned away Pfizer Inc's bid to revive its plan to cover out-of-pocket expenses of Medicare patients for drugs costing $225,000 a year to treat a rare heart condition after federal officials found that the drugmaker's arrangement could amount to illegal kickbacks."
date = "2023-01-10 04:25:36"
slug = "63bce89e6941a01d4c8e88ba"
image = "https://i.imgur.com/gkQXCTG.jpg"
score = "1507"
categories = ['pfizers', 'drugs', 'federal']
+++

The U.S. Supreme Court on Monday turned away Pfizer Inc's bid to revive its plan to cover out-of-pocket expenses of Medicare patients for drugs costing $225,000 a year to treat a rare heart condition after federal officials found that the drugmaker's arrangement could amount to illegal kickbacks.

## Highlights

- The U.S.
- Supreme Court turned away Pfizer Inc's bid to revive its plan to cover out-of-pocket expenses of Medicare patients for drugs costing $225,000 a year to treat a rare heart condition.
- The justices took up Pfizer's appeal of a lower court's ruling that agreed with the government's view that the company's proposal to cover cost-sharing co-payments required of patients to use its drugs could violate a federal law called the Anti-Kickback Statute.
- An estimated 100,000 to 150,000 Americans, mostly elderly, have the condition known as transthyretin amyloid cardiomyopathy.

---

{{< rawhtml >}}
  <p class="article-category">
    <a target="_blank" href="https://www.reuters.com/legal/us-supreme-court-rebuffs-pfizer-plan-help-patients-pay-heart-medication-2023-01-09/">READ THE ORIGINAL ARTICLE</a>
  </p>
{{< /rawhtml >}}
